Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma

被引：0
|
作者：
Meiyan Liang
Masaki Ueno
Souichi Oomizu
Tomohiro Arikawa
Rika Shinonaga
Shulan Zhang
Akira Yamauchi
Mitsuomi Hirashima
机构：
[1] Kagawa University,Department of Immunology and Immunopathology, Faculty of Medicine
[2] China Medical University,Department of Gynecology and Obstetrics, Shengjing Hospital
[3] Kagawa University,Department of Inflammation Pathology, Faculty of Medicine
[4] GalPharma Co. Ltd,Department of Cell Regulation, Faculty of Medicine
[5] Kagawa University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2008年 / 134卷
关键词：
Human; Cervical cancer; Galectin-9;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：899 / 907
页数：8
相关论文
共 50 条
  • [1] Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma
    Liang, Meiyan
    Ueno, Masaki
    Oomizu, Souichi
    Arikawa, Tomohiro
    Shinonaga, Rika
    Zhang, Shulan
    Yamauchi, Akira
    Hirashima, Mitsuomi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (08) : 899 - 907
  • [2] Galectin-9 Expression is Correlated to Cervical Squamous Cell Carcinoma Progression and Overall Survival
    Mendieta-Carmona, Victoriano
    Delgado-Lopez, Guadalupe
    Reyes-Leyva, Julio
    Gutierrez-Quiroz, Claudia Teresita
    Vazquez-Zamora, Victor Javier
    Picazo-Mendoza, Denisse Alejandra
    Montiel-Jarquin, Alvaro Jose
    Martinez-Morales, Laura Patricia
    Vallejo-Ruiz, Veronica
    ONCOTARGETS AND THERAPY, 2023, 16 : 891 - 904
  • [3] Expression of galectin-9 mRNA in hepatocellular carcinoma
    Liang, Yong
    Chen, Jiayu
    Zhang, Yanzi
    Zhang, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 15100 - 15105
  • [4] Loss of Galectin-9 from head and neck squamous cell carcinoma is a potent indicator of malignant transformation.
    Steffl, Martin
    Fik, Zdenek
    Valach, Jaroslav
    Smetana, Karel
    Chovanec, Martin
    Kodet, Ondrej
    Gabius, Hans Joachim
    Plzak, Jan
    FASEB JOURNAL, 2013, 27
  • [5] Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines
    Kasamatsu, A
    Uzawa, K
    Nakashima, D
    Koike, H
    Shiiba, M
    Bukawa, H
    Yokoe, H
    Tanzawa, H
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 16 (02) : 269 - 273
  • [6] The Significance of Galectin-1 and Galectin-9 Expression in Endometrial Carcinoma
    Sun, Xiao-fei
    Dai, Shu-yan
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2020, 85 (01) : 34 - 40
  • [7] Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma
    Ryosuke Jikuya
    Takeshi Kishida
    Masahiko Sakaguchi
    Tomoyuki Yokose
    Masato Yasui
    Akihito Hashizume
    Tomoyuki Tatenuma
    Nobuhiko Mizuno
    Kentaro Muraoka
    Susumu Umemoto
    Masaki Kawai
    Mitsuyo Yoshihara
    Yoshiyasu Nakamura
    Yohei Miyagi
    Tetsuro Sasada
    Cancer Immunology, Immunotherapy, 2020, 69 : 2041 - 2051
  • [8] Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma
    Jikuya, Ryosuke
    Kishida, Takeshi
    Sakaguchi, Masahiko
    Yokose, Tomoyuki
    Yasui, Masato
    Hashizume, Akihito
    Tatenuma, Tomoyuki
    Mizuno, Nobuhiko
    Muraoka, Kentaro
    Kawai, Masaki
    Yoshihara, Mitsuyo
    Nakamura, Yoshiyasu
    Miyagi, Yohei
    Sasada, Tetsuro
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 2041 - 2051
  • [9] Changed Expression of E-cadherin and Galectin-9 in Oral Squamous Cell Carcinomas but Lack of Potential as Prognostic Markers
    Chan, Siew Wui
    Kallarakkal, Thomas George
    Abraham, Mannil Thomas
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (05) : 2145 - 2152
  • [10] Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
    Zhang, Zhao-Yang
    Dong, Jia-Hong
    Chen, Yong-Wei
    Wang, Xian-Qiang
    Li, Chong-Hui
    Wang, Jian
    Wang, Guo-Qiang
    Li, Hai-Lin
    Wang, Xue-Dong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (06) : 2503 - 2509
12345